Toronto Dominion Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Buy |
|
|||||
|
2025
Q1 | $2.02M | Buy |
|
|||||
|
2024
Q4 | $1.63M | Buy |
|
|||||
|
2024
Q3 | $1.68M | Buy |
|
|||||
|
2024
Q2 | $1.5M | Sell |
|
|||||
|
2024
Q1 | $1.73M | Sell |
|
|||||
|
2023
Q4 | $42.1M | Sell |
|
|||||
|
2023
Q3 | $80.3M | Buy |
|
|||||
|
2023
Q2 | $4.07M | Sell |
|
|||||
|
2023
Q1 | $5.28M | Sell |
|
|||||
|
2022
Q4 | $5.89M | Buy |
|
|||||
|
2022
Q3 | $3.48M | Buy |
|
|||||
|
2022
Q2 | $3.4M | Buy |
|
|||||
|
2022
Q1 | $3.03M | Buy |
|
|||||
|
2021
Q4 | $3.19M | Buy |
|
|||||
|
2021
Q3 | $2M | Buy |
|
|||||
|
2021
Q2 | $2.05M | Buy |
|
|||||
|
2021
Q1 | $1.85M | Sell |
|
|||||
|
2020
Q4 | $2.99M | Buy |
|
|||||
|
2020
Q3 | $2.33M | Buy |
|
|||||
|
2020
Q2 | $3.43M | Buy |
|
|||||
|
2020
Q1 | $2.18M | Sell |
|
|||||
|
2019
Q4 | $2.69M | Buy |
|
|||||
|
2019
Q3 | $1.97M | Sell |
|
|||||
|
2019
Q2 | $2.42M | Buy |
|
|||||
|
2019
Q1 | $2.88M | Buy |
|
|||||
|
2018
Q4 | $2.07M | Buy |
|
|||||
|
2018
Q3 | $1.9M | Buy |
|
|||||
|
2018
Q2 | $1.65M | Buy |
|
|||||
|
2018
Q1 | $974K | Buy |
|
|||||
|
2017
Q4 | $921K | Buy |
|
|||||
|
2017
Q3 | $686K | Buy |
|
|||||
|
2017
Q2 | $193K | Buy |
|
|||||
|
2017
Q1 | $165K | Buy |
|
|||||
|
2016
Q4 | $123K | Buy |
|
|||||
|
2016
Q3 | $130K | Buy |
|
|||||
|
2016
Q2 | $69K | Buy |
|
|||||
|
2016
Q1 | $73K | Buy |
|